Cricopharyngeal achalasia after stroke
Conditions
Interventions
Control group:Simple basic medication and routine rehabilitation treatment
Botulinum toxin injection group:Implementing botulinum toxin injection therapy on the basis of basic medication and routine rehabilitation treatment
Acupuncture group:Implement acupuncture treatment based on basic medication and routine rehabilitation therapy
BTX+Acupuncture group:Implement botulinum toxin injection therapy combined with acupuncture treatment on the basis of basic medication and routine rehabilitation treatment
Sponsors
Wenzhou Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
40 Years to 85 Years
Inclusion criteria
Inclusion criteria: (1) age of 85 years old and below; (2) patients who met the diagnostic criteria of stroke in the "Diagnostic Points of Major Cerebrovascular Diseases in China 2019"; (3) first unilateral or bilateral cerebral hemisphere stroke confirmed by head CT or MRI; (4) conscious patients with stable vital signs; (5) There was no improvement in swallowing function after standard rehabilitation treatment for more than 2 weeks when the course of dysphagia was more than 1 month; (6) Functional oral intake Scale (FOIS) score = 2; (7) Cricopharyngeal achalasia symptoms such as cricopharyngeal stenosis or closed cricopharyngeal muscle were confirmed by videofluoroscopic swallowing examination (VFSS); (8) be able to understand and cooperate with the instructions of the treatment staff; (9) voluntarily participated in the study, cooperated with the examination and treatment, and signed the informed consent.
Exclusion criteria
Exclusion criteria: (1) Patients were in the acute stage of unstable vital signs or severe chronic disease exacerbation; (2) patients with epilepsy history; (3) dysphagia caused by other neurogenic diseases; (4) with metal foreign bodies in the brain or heart, or wearing cardiac pacemaker, cochlear implant and other implants; (5) skin and soft tissue damage, infection, bleeding, rash and structural abnormalities in oral cavity, pharynx and esophagus; (6) patients with a history of allergy to botulinum toxin.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Functional oral food intake Scale;Standardized swallowing assessment;Swallowing-related quality of life;Video fuoroscopic swallowing study;Video fuoroscopic dysphagia scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Grading of drinking test;Self-rating anxiety scale;Self-rating depression scale; | — |
Countries
China
Contacts
Public ContactDengchong Wu
Wenzhou Hospital of Traditional Chinese Medicine
Outcome results
None listed